{"version":"1.0","provider_name":"The Medical Xchange","provider_url":"https:\/\/themedicalxchange.com\/en\/","title":"Biomarkers of Severe Asthma May Help Better Direct Emerging Therapies - The Medical Xchange","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"4210xLh6jr\"><a href=\"https:\/\/themedicalxchange.com\/en\/2016\/05\/25\/american-thoracic-society-ats-2016-international-2\/\">Biomarkers of Severe Asthma May Help Better Direct Emerging Therapies<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/themedicalxchange.com\/en\/2016\/05\/25\/american-thoracic-society-ats-2016-international-2\/embed\/#?secret=4210xLh6jr\" width=\"600\" height=\"338\" title=\"&#8220;Biomarkers of Severe Asthma May Help Better Direct Emerging Therapies&#8221; &#8212; The Medical Xchange\" data-secret=\"4210xLh6jr\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/themedicalxchange.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2016\/05\/2359_ATS_2016_report_EN_Fig1.PNG","thumbnail_width":960,"thumbnail_height":720,"description":"San Francisco \u2013 In asthma patients with frequent and difficult-to-control exacerbations, data from the Severe Asthma Research Program (SARP) promises to guide the newest targeted therapies to the underlying pathophysiology. Data presented at this year\u2019s ATS from the SARP program suggest that highly-specific biomarkers are likely to allow expensive but effective emerging therapies to be used to reduce both the risk of life-threatening events and excess consumption of healthcare resources."}